SORT BY Relevancy
Dr. Roger Tiedemann is a scientist at the Ontario Cancer Institute and a hematologist specializing in multiple myeloma and lymphoma within the division of Medical Oncology and Hematology at the Princess Margaret Cancer Center and is an Assistant Professor of Medicine at the University of Toronto with appointments from the Department of Medical Biophysics and in the Department of Medicine. Dr. Tiedemann is a New Zealand-trained hematologist and fellow of both the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Hes an author of a US patent application for a new cell cycle therapeutic. His research focus includes multiple myeloma stems, progenitor cells, genomics and the development of new therapeutic strategies for myeloma based on an understanding of the tumor biology.
RSVP here! (or) mail email@example.com
Our guest today is Bob Dobbins, Vice President, New Business Development at Panasonic Corporation of North America. We will be talking to him today about Panasonic's upcoming Innovation HealthJam.
The Innovation HealthJam is a completely virtual event that brings together a diverse and knowledgeable group of people from the healthcare and technology fields to brainstorm ideas, improvements and innovation in healthcare. The event is co-hosted by a group of healthcare industry leaders and led by Panasonic's Innovation Group. Sponsors include leading healthcare industry organizations:
The American Medical Association
The Center for Technology and Aging
The Center for Information Technology Research in the Interest of Society (CITRIS)
Healthcare Information and Management Systems Society (HIMSS)
Personal Connected Health Alliancs (PCHA), a collaboration between Continua Health Alliance, mHealth Summit and HIMSS; along with technology providers Intel and Panasonic, and academic institutions UC Davis and UCSF
There are eight focus areas for the Jam:
Patient Engagement and Healthcare Design for Consumers
Technology and Older Adults: The New Era of Connected Aging
A Mobile Health Agenda for Transforming Healthcare Delivery
Compute for Personalized Medicine: Finding the Cause and Cure through Genomics
Telehealth and Telemedicine: Emerging Opportunities in Addressing the Triple Aim
Your Physician of the Future
Health Innovation for Vulnerable Populations - Worldwide
Remote Patient Monitoring (RPM)
Join us for an exciting discussion - Mr. Dobbins will be taking questions on air.
This episode is sponsored by Panasonic USA.
DNA mapping is it the gateway for Eugenics? Can we trust those who have used us?
"Assessing the work of Charles Darwin, and pondering the experience of animal breeders and horticulturists, Francis Galton wondered if the human genetic make-up could be improved: “The question was then forced upon me - Could not the race of men be similarly improved? Could not the undesirables be got rid of and the desirables multiplied?”This concept of eugenics - a term he introduced - soon won many adherents, notably in North America and England. First practical steps were taken in the United States of America. The government under Theodore Roosevelt created a national Heredity Commission that was charged to investigate the genetic heritage of the country and to “(encourage) the increase of families of good blood and (discourage) the vicious elements in the cross-bred American civilization”.
Don't be Educated in Ignorance!
Join in the conversation on I was just thinking... brought to you by the Caribbean Radio Show-The Knowlwdge Station every Friday evening 5-7pm pacific time and 8-10pm eastern time.
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.
Listen to cytogenetics and genomics expert Dr. Rafael Fonseca, MD of the Mayo Clinic in Scottsdale share the latest in his myeloma research and his open clinical trials.
On the Wednesday, July 24th, 2013 broadcast at 2PM Pacific/5PM Eastern our special guest is entrepreneur, social media thought leader and Forbes Contributor Dan Munro aka @danmunro.
Dan recently penned a piece for Forbes titled: 'Big Government Opens Big Database For Cancer Research'
This catchy headline caught my attention since part of our mission at This Week In Oncology is to eliminate the esoterica from 'oncology-speak' and to present the significance of the discoveries, trends and developments in the cancer care and diagnostics in plain english for more general consumption.
Much progress has been realized in oncology of late with a fair amount of the promisesd upside of 'personalized [or individualized] medicine' often pointing to better outcomes via more targeted treatment of specific tumors based on their unique genetic signature.
So called 'big data' is in the news as ubiquitous technology, connectivity, the declining costs of massive data dragnets and disease specific mashups affords insights previously inaccessible to reseachers, clinicians and others interested in the diagnosis and/or treatment of oncology.
We'll get Dan's takes on his piece and see how he sees the confluence of these trends coming together for the benefits of patients.
On the Wednesday, January 23rd 2013 broadcast our guest is Dr. Jeff Hall, Ph.D. Vice President of Cell Biology at GenOptix. Dr. Hall is making an encore apperance on This Week in Oncology (TWiO). Learn more about GenOptix here.
Topic: Biomarkers their emerging clinical significance in the diagnosis and treatment of cancer.
With over 20 years of experience in the life sciences industry, Jeff Hall, PhD is currently the Vice President of Clinical Education at Genoptix, a division of Novartis. He spends most of his time interacting with physicians, working to get Genoptix’ cutting edge hematopathology services in the hands of the oncologists and pathologists whose patients will benefit from the state of the art testing services and reports which Genoptix offers. Dr. Hall holds a B.A. in Biology and Chemistry from U.C. Santa Cruz and a Ph.D. in Biochemistry from U.C. Berkeley. Dr Hall was the first author on the landmark 1990 Science paper describing the location of BRCA I on chromosome 17q. Prior to joining Genoptix, Dr. Hall was Vice President of Genomics at PPGx in La Jolla. While there, he was responsible for running three laboratory genetics groups in the United States and Europe. Dr. Hall also worked at Axys Pharmaceuticals in 1998 as Senior Director of Genomics and from 1996 to 1997 at Sequana Therapeutics as Director of Genetics. From 1992 to 1995 Dr. Hall was the Director of Genetics at CellPro.
The answer is not in finding better doctors or better drugs, or even better treatment facilities. The best answer is prevention. What if you do not even experience a disease in the first place? Let's Contrast Pasteur with Vincent. Two great scientists from the past. One believed that health was out of your control and that germs were responsible. The other believed in biological terrain, or the health of you internal "terrain". Who was right? Let's explore how to not get sick, then we won't need such a large medical complex.
Max McCoy speaks with Joyce about his recent personal adventure, exploring the depths of his own genome. It's an ongoing adventure worthy of some of his fictional heroes -- unexpected twists and turns, sometimes more information than you know what to do with, and often more questions than answers are unearthed. Max McCoy is an award-winning author and journalist. He's the author of four original Indiana Jones adventures for Lucasfilm, the critically acclaimed thriller The Moon P
On the Wednesday July 18th, 2012 program at 1:30PM Pacific/4:30 Eastern, we're delighted to book time with tireless author, cardiologist, academic thought leader, and even social media enthusuast, Eric Topol, MD. A man who wears many hats, but one of his most recent contributions comes in the form of a landmark book titled 'The Creative Destruction of Medicine' (CDoM). For his aggregate work, Dr. Topol was recently tagged by Modern Healthcare as #1 'Most Influential Physician E